<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
<journal-title-group>
<journal-title>Scientific Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2045-2322</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31862965</article-id>
<article-id pub-id-type="pmc">6925119</article-id>
<article-id pub-id-type="publisher-id">56149</article-id>
<article-id pub-id-type="doi">10.1038/s41598-019-56149-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Sheng</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Jiang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ouyang</surname>
<given-names>Ting</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Xiu-Yin</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Fen</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qu</surname>
<given-names>Yu-hua</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Min</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Luo</surname>
<given-names>Tao</given-names>
</name>
<address>
<email>luot8@mail.sysu.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Hua-Qiao</given-names>
</name>
<address>
<email>wanghq@mail.sysu.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2360 039X</institution-id><institution-id institution-id-type="GRID">grid.12981.33</institution-id><institution>Department of Anatomy and Neurobiology, Zhongshan School of Medicine, </institution><institution>Sun Yat-sen University, </institution></institution-wrap>Guangzhou, Guangdong 510080 China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0472 9649</institution-id><institution-id institution-id-type="GRID">grid.263488.3</institution-id><institution>Department of Anatomy, Histology and Developmental Biology, School of Basic Medical Sciences, </institution><institution>Shenzhen University Health Science Centre, </institution></institution-wrap>Shenzhen, 518060 China </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2360 039X</institution-id><institution-id institution-id-type="GRID">grid.12981.33</institution-id><institution>Pediatric Hematology and Oncology, Affiliated Guangzhou Women and Children’s Hospital, Zhongshan School of Medicine, </institution><institution>Sun Yat-Sen University, </institution></institution-wrap>Guangzhou, 510623 China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>20</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>9</volume>
<elocation-id>19575</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>12</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Alzheimer’s disease (AD) is a complex disorder influenced by both genetic and environmental components and has become a major public health issue throughout the world. Oxidative stress and inflammation play important roles in the evolution of those major pathological symptoms. Jatrorrhizine (JAT), a main component of a traditional Chinese herbal, coptidis rhizome, has been shown to have neuroprotective effects and we previously showed that it is also able to clear oxygen free radicals and reduce inflammatory responses. In this study, we demonstrated that JAT administration could alleviate the learning and memory deficits in AD. Furthermore, we also found that JAT treatment reduced the levels of Aβ plaques in the cortex and hippocampus of APP/PS1 double-transgenic mice. Other studies suggest that there are gut microbiome alterations in AD. In order to explore the underlying mechanisms between gut microbiota and AD, DNA sequencing for 16s rDNA V3-V4 was performed in fecal samples from APP/PS1 transgenic mice and C57BL/6 wild-type (WT) mice. Our results indicated that APP/PS1 mice showed less Operational Taxonomic Units (OTUs) abundance in gut microbiota than WT mice and with different composition. Furthermore, JAT treatment enriched OTUs abundance and alpha diversity in APP/PS1 mice compared to WT mice. High dose of JAT treatment altered the abundance of some specific gut microbiota such as the most predominant phylum Firmicutes and Bacteroidetes in APP/PS1 mice. In conclusion, APP/PS1 mice display gut dysbiosis, and JAT treatment not only improved the memory deficits, but also regulated the abundance of the microbiota. This may provide a therapeutic way to balance the gut dysbiosis in AD patients.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Alzheimer's disease</kwd>
<kwd>Drug development</kwd>
<kwd>Molecular medicine</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003453</institution-id>
<institution>Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)</institution>
</institution-wrap>
</funding-source>
<award-id>2015A030313066, 2015A030310251, 2017A030313904</award-id>
<award-id>2017A030313904</award-id>
<award-id>2015A030310251</award-id>
<principal-award-recipient>
<name>
<surname>Jiang</surname>
<given-names>Wei</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Tao</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Hua-Qiao</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China (National Science Foundation of China)</institution>
</institution-wrap>
</funding-source>
<award-id>81501093</award-id>
<principal-award-recipient>
<name>
<surname>Wang</surname>
<given-names>Hua-Qiao</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Medical Scientific Research Foundation of Guangdong Province(No. A2016618);</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Alzheimer’s disease (AD) is characterized by progressive impairment of cognition and memory as well as pathological hallmarks which include extracellular amyloid plaques, intracellular neurofibrillary tangles and neuronal loss.AD mainly affects the elderly who undergo slow but progressive loss of memory and cognitive functions. The pathological changes of AD include atrophy of the cortex, widening of the sulci, enlargement of the ventricles and substantial reduction of neurons. These pathological changes are characterized by significant accumulation of proteinaceous fibrillary substances and neurofibrillary tangles as well as reduction of choline acetylcholine and acetylcholine<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. AD has been studied extensively for decades, however, the disease pathogenesis still remains unclear and there has been no effective treatment discovered yet. Previous AD research mainly focusses on Aβ production and degradation, tau abnormal phosphorylation, and other brain-related aspects. Recently, intestinal microbiome has been shown to be one of the emerging risk of AD progression<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>.</p>
<p id="Par3">In humans, only half of the cells and a tiny number of genes are unique, and the rest can be found in gut microbiota such as viruses, archaea and fungi. There has been a rise in the understanding of human diseases and the emerging medical prospects of gut microbiome<sup><xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR6">6</xref></sup>. Gut microbiota has been shown to contribute to many complex central nervous system disorders<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. For instance, alterations of gut microbiota have been identified in many neurodegenerative diseases such as Parkinson’s disease<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>, multiple sclerosis<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, autism disorder<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> and AD<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. Phyla or strains of bacteria in feces of 5xFAD Alzheimer’s mice Model are distinguishable from their wild type littermate<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Microbial colonies of AD patients have been characterized compositionally different from that of control individuals<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Furthermore, correlation analyses of gut microbiota and blood cytokines suggest that gut microbiota may promote brain inflammation. Some studies reported that gut-microbiota-related dysbiosis will enhance inflammation and gut’s leakiness<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, and through a web of interactions, it increases neuronal dysfunction and apoptosis, at the same time, promotes learning and memory impairment<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>. Other studies suggest that there are gut microbiome alterations in AD, and learning and memory impairment was related to gut microbiota disorder in aging mice<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Studies by Harach <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, further revealed that the germ-free APP transgenic mice showed a significant decrease in cerebral Aβ levels compared with control mice.</p>
<p id="Par4">With the progression of research on Alzheimer’s disease, different drugs have been extensively investigated. However, most of them just improve the severity of disease symptoms without finding successfully the fundamental causes<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Therefore, it is crucial to find drug candidates targeting the prevention of neural loss as well as the alleviation of Aβ aggregation<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Jatrorrhizine (JAT) is a tetrahydro-isoquinoline alkaloid isolated from a traditional Chinese medicine Huang Lian that is capable of sterilization and often used as a detoxification and anti-hyperglycemic agent. A number of studies confirmed that JAT has multiple biological functions such as anti-oxidation<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Our previous studies indicated JAT can be used to protect neurons against hydrogen peroxide or Aβ oligomer induced cell damage<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. JAT has potential to clear oxygen free radicals and to reduce the inflammatory responses on neurons. We also demonstrated that JAT can alleviate the impairment of learning and memory abilities in APP/PS1 mice in this study. Donepezil hydrochloride, as an acetylcholinesterase inhibitor, is a long-acting drug to treat symptoms of AD<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Here, we used it as a positive control to evaluate the effect of JAT on AD.</p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="Sec3">
<title>Reagents and antibodies</title>
<p id="Par5">JAT (C<sub>20</sub>H<sub>20</sub>NO<sub>4</sub>, FW 338.38, purity &gt; 98%) was obtained from Chengdu Herbpurify co., LTD (Chengdu, Sichuan, China). Poly (ethylene glycol) average Mn300 (H(OCH<sub>2</sub>CH<sub>2</sub>)nOH) and DONE (C<sub>24</sub>H<sub>29</sub>NO<sub>3</sub> · HCl · H<sub>2</sub>O, FW 433.97, purity &gt;98%) were purchased from Sigma-Aldrich (Saint Louis, Mo, USA). Physiological saline for i.p. injection was bought from Guangzhou Cisen medical Science and Technology Co., LTD (Guangzhou, Guangdong, China). JAT was dissolved in poly (ethylene glycol) and diluted with saline. Antibodies used for immunostaining were anti-amyloid-β (clone 6E10, Catalog SIG-39320, Covance), anti-GFAP polyclonal antibody (Catalog AB5541, Millipore Corporation), Cy5 (Jackson Immunoresearch, USA), Alexa Fluor 488 (Jackson Immunoresearch, USA).</p>
</sec>
<sec id="Sec4">
<title>Animals and drug administration</title>
<p id="Par6">APP/PS1 transgenic mice (male, APP/PS1) and wild-type (male, C57BL/6) mice were purchased from Guangdong Medical Laboratory Animal Research Institute. Twenty-four APP/PS1 mice were randomly allocated to receive high dose JAT (JATH, n = 6), low dose JAT (JATL, n = 6), saline (APP/PS1, n = 6), donepezil hydrochloride monohydrate (DONE, n = 6) for 24 weeks at an age of 3 months. Six age-matched C57BL/6 mice were also being given saline for 24 weeks via intraperitoneal injection. The mice were housed in an air-conditional room (temperature 19 °C~23 °C), under a circadian rhythm ensuring night time of more than 12 hours (lights on from 07:00 am to 07:00 pm) with free access to sterile water and food. The animal experiments were approved by the Institutional Animal Care and Use Committee(IACUC), Sun Yat-Sen University, and all animal care and procedures conform to the National Institutes of Health Guide for Care and Use of Laboratory Animals. JATH and JATL were intraperitoneally administered at the doses of 10 mg/kg/day and 5 mg/kg/day, respectively, for 6 months. Mice in group DONE were treated with DONE at the dose of 0.3 mg/kg/day through intraperitoneal injection. Age-matched mice in group APP/PS1 and C57BL/6 were injected with equal volume of physiological saline.</p>
</sec>
<sec id="Sec5">
<title>Morris water maze test</title>
<p id="Par7">To assess the spatial learning and memory abilities of APP/PS1 mice and WT mice, Morris water maze test was performed in a water tank with a diameter of 80 cm which was filled with water (19 °C~23 °C). The tank was divided into four equidistant quadrants. Titanium dioxide was added to keep water opaque, and water was added until it was 1 cm over the platform. The procedure included acquisition trail and probe trial sections. From day 1 to day 5, mice were devoted into the tank in one of the four quadrants to find the hidden-platform, the escape latency (time taken to find the platform) was recorded using a computer-controlled video tracking system to analyze the spatial learning ability. The mice that failed to find the platform within 60 s were manually guided to the platform for several minutes. Probe trial was carried out on day 6, the platform was removed, and the mice was allowed to swim for 60 s, and the time spent in the target quadrant and number of times that the mice crossed the position where the platform used to be located were recorded and analyzed to assess the spatial memory(Vorhees and Williams, 2006).</p>
</sec>
<sec id="Sec6">
<title>Immunostaining</title>
<p id="Par8">After behavioural test, mice were anesthetized with 2% urethane and perfused with 0.9% NaCl. The brains of three wild-type and twelve APP/PS1 mice were removed and fixed in 4% paraformaldehyde (in PBS) at 4 °C for a week. After dehydration in 30% sucrose (in PBS), 30-μm-thick slices were cut using a Cryostat (CryoStar NX50, Thermo Scientific, USA). For general immunostaining, sections were pre-treated by formic acid (70%) for 10~30 minutes at room temperature, and then washed in PBS for three times and blocked in 5% normal goat serum supplemented with 0.1% Triton X-100 (in PBS) at room temperature for 1 h. Primary antibodies (anti-Aβ monoclonal antibody, Catalog SIG-39320, Covance, USA; anti-GFAP polyclonal antibody, Catalog AB5541, Millipore Corporation) were incubated at 4 °C overnight. On the second day, the sections were washed thrice in PBS for 3 times and corresponding species-derived fluorophore (Cy5, Jackson Immunoresearch, USA; Alexa Fluor 488, Jackson Immunoresearch, USA)-conjugated secondary antibodies were added at room temperature and incubated for 1 h. Hoechst 33342 (Sigma-Aldrich) was used for the visualization of nuclei. After another three rounds of washes in PBS, images of hippocampal region along the AP axis (Bregma −1.5 ~ −2.5 mm) were mounted and imaged using fluorescent microscope (BX63, Olympus, Japan).</p>
</sec>
<sec id="Sec7">
<title>Quantification of Aβ plaques and reactive astrocytes</title>
<p id="Par9">The Aβ plaques and reactive astrocytes were quantified by a blinded observer using ImageJ in three sections per brain (Bregma, −1.5 mm to −2.5 mm) in 3 animals per group. We chose ten appropriate fields in each slice and calculated the arithmetic means of each region. Among all parameters, cells at the edge of the tissue sections were not considered for evaluation to avoid human error statistics maximally. We manually adjusted the analyzed areas so that only the area of interest was accurately measured with each measurement, and adjusted to exclude brains regions other than the cortex and hippocampus. The area of Aβ plaques in the cross section of the brain was recorded, as well as the total number of Aβ plaques determined by immunostaining. To quantify reactive astrocytes, the percentage of threshold pixels per image to the total pixels in the region of interest was calculated and presented as the percentage of affected tissue.</p>
</sec>
<sec id="Sec8">
<title>16S rDNA amplicon sequencing of gut microbiota</title>
<p id="Par10">After administrating JAT, DONE or saline for 6 consecutive months (before the Morris water maze test), the feces were collected at successive a few mornings and frozen to ultra-low temperature refrigerator until use. Total genomic DNA (gDNA) of fecal samples was isolated using PowerSoil-htp 96 Well Soil DNA Isolation Kit (12955, Mobio, USA) according to the manufacturer’s protocol. Universal primers employed to amplify V3-V4 regions of bacterial 16S rDNA genes from gDNA were 5′-ACTCCTACGGGAGGCAGCA-3′ and 5′-GGACTACHVGGGTWTCTAAT-3′. The libraries were sequenced on Illumina Hiseq platform (Illumina, San Diego, CA, USA) to generate 2 × 250-bp pair-end sequencing reads according to the standard protocol provided by Illumina.</p>
</sec>
<sec id="Sec9">
<title>Sequence analysis</title>
<p id="Par11">PE reads were spliced through the overlap by using FLASH v1.2.7 software, then the original Tags data (Raw Tags) was obtained. High quality Tags were generated by filtering the raw tags in Trimmomatic v0.33 software. We used UCHIME v4.2 software to identify and remove chimeras Sequence, and to get the final effective data (Effective Tags). Operational taxonomic unit (OTU) was clustered and taxonomic annotation were performed in QIIME (version 1.8.0)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. The abundance of species at different levels (phylum, class, order, family, genus, and species) of classification was also by performing the QIIME software (version 1.8.0). Mothur (version v.1.30) was used to generate alpha diversity indices (observed OTU, ACE index, Chao1 index, Simpson index, Shannon index and Goods coverage)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. QIIME (version 1.8.0) was also used to measure beta diversity indices (unweighted UniFrac distance and weighted UniFrac distance)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Line Discriminant Analysis (LDA) Effect Size (Lefse) analysis was used for screening significantly different biomarkers<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. To study the differences in the abundance of microbial colonies between the two groups of samples, the species abundance data between groups were tested by Metastats<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. PICRUSt software relates the functional genes in the sample by comparing the species composition information obtained from the 16S sequencing data to analyze the functional differences between the different samples or groups<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Correlation analysis was performed according to Sparcc algorithm<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p>
</sec>
<sec id="Sec10">
<title>Statistical analysis</title>
<p id="Par12">Date analyses were performed with SPSS 23.0. Data obtained from acquisition trail were analyzed by repeated measures and multivariate analysis of variance (ANOVA) process of the genera linear model in SPSS, post hoc comparisons were assessed using the LSD test or Dunnett’s T3 test. The other data were presented as the mean with the standard error of mean (SEM). Verifying that the mean values of multiple groups was performed using a one-way analysis of variance test (ANOVA) and the differences between groups were compared with the least significant difference test. Results were considered statistically significant when p &lt; 0.05. GraphPad Prism (version 7) was used to conduct statistical tests and graphs.</p>
</sec>
<sec id="Sec11">
<title>Ethics approval and consent to participate</title>
<p id="Par13">The animal experiments were approved by the Animal Ethical and Welfare Committee of SYSU, and all animal care and procedures conform to the National Institutes of Health Guide for Care and Use of Laboratory Animals.</p>
</sec>
</sec>
<sec id="Sec12" sec-type="results">
<title>Results</title>
<sec id="Sec13">
<title>JAT ameliorated learning and memory deficits in APP/PS1 transgenic mice</title>
<p id="Par14">We injected different concentrations of JAT intraperitoneally to three months old male APP/PS1 mice for 6 months, while the age-matched male wild-type (WT) control received the vehicle (n = 6) (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>). We subjected all these mice to a Morris water maze test 2 days after the last administration of JAT to assess alterations in learning and memory abilities.<fig id="Fig1"><label>Figure 1</label><caption><p>JAT ameliorated learning and memory deficits in APP/PS1 transgenic mice. (<bold>a</bold>) Schedule of behavioral test. Three-month-old male APP/PS1 mice were intravenously injected with different concentrations of Jatrorrhizine (5 mg/kg, 10 mg/kg, n = 6*2), DONE (0.3 mg/kg/day, n = 6) and vehicle (2.5% DMSO in PBS, n = 6) for 6 months (1 time per day). As controls, age-matched male wild-type (Wt) mice were injected with vehicle (2.5% DMSO in PBS, n = 6) for 6 months. (<bold>b</bold>) Jatrorrhizine administration groups have shown shorter escape latencies to the hidden platform in comparison to the vehicle-treated APP/PS1 mice. (<bold>c</bold>) During the acquisition trial, there are no significant differences in the swimming speed of mice. In the probe trial, APP/PS1 mice treated with Jatrorrhizine showed more exploratory distance (<bold>d</bold>) and time (<bold>e</bold>) in the target quadrant compared with the vehicle-treated APP/PS1 mice. Data information: The data are expressed as mean ± SEM. For statistical significance, <sup>###</sup>P &lt; 0.001 compared to WT mice, *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001 compared to vehicle-treated APP/PS1 mice.</p></caption><graphic id="d29e555" xlink:href="41598_2019_56149_Fig1_HTML"></graphic></fig></p>
<p id="Par15">The Morris water maze assay was used to measure the spatial learning and memory in APP/PS1 mice. During the acquisition trail, the mice showed a gradual reduction in the time required to locate the platform (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>). Repeated measures ANOVA indicated that there were significant differences in latent phases between all experimental groups. The Dunnett’s multiple comparisons test suggested that WT and DONE group exhibited a shorter escape latency than vehicle-treated APP/PS1 mice at days 5 (P &lt; 0.01) of acquisition trails. It was noteworthy that the swimming speed of mice did not show any statistically significant difference among all groups (P &gt; 0.05). This result indicated that the differences in escape latencies were not due to the travel rate of mice (Fig. <xref ref-type="fig" rid="Fig1">1c</xref>). About 24 hours after the last acquisition training, hidden platform was removed from the target quadrant and the mice were tested for spatial memory in the probe trials. As shown in Fig. <xref ref-type="fig" rid="Fig1">1d,e</xref>, analysis by one-way ANOVA displayed remarkable differences among each group (P &lt; 0.01). The Dunnett’s multiple comparisons test revealed that compared to WT mice, APP/PS1 mice treated with vehicle spent the minimum time exploring and also moved the least within the target quadrant. However, these behavioral deficits were reversed by 6 months long JAT administration in APP/PS1 transgenic mice. JAT has a marked impact on both two dose groups, which significantly increased the time spent in the target quadrant by APP/PS1 mice. In addition, JAT also obviously increased exploratory distance the APP/PS1 mice moved in the platform quadrant.</p>
</sec>
<sec id="Sec14">
<title>JAT significantly reduces Aβ plaques in the cortex and hippocampus of APP/PS1 mice</title>
<p id="Par16">Pathogenesis of AD involves Aβ aggregating into insoluble clusters or plaques in the brain<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, and this formation of these plaques contributes to the learning and memory deficits<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Given that pretreatment with different concentrations of JAT can obviously inhibit neurotoxicity, we hypothesized that JAT might act on Aβ aggregates directly to alleviate the neurotoxicity in AD.</p>
<p id="Par17">To assess the effect of JAT on plaque formation in the brain, we evaluated the levels of Aβ plaques in mice that underwent behavioral tests. Evidence from previous studies have suggested that diffuse Aβ plaques in AD are relevant to reactive astrocytes that converge around them<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> leading to neurodegenerative events<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Hence, in order to detect reactive astrocytes and diffuse plaques in the brains of mice, we performed immunostaining respectively, using anti-glial fibrillary acidic protein (GFAP) antibody and 6E10 antibody. We clearly observed the co-localization of reactive astrocytes and diffuse plaques in APP/PS1 mice brains (Fig. <xref ref-type="fig" rid="Fig2">2b,c</xref>). In addition, our results further showed that JAT administration had a reduced expression of diffuse plaques and GFAP in the hippocampus and cortex of APP/PS1 transgenic mice (Fig. <xref ref-type="fig" rid="Fig2">2a,d</xref>). Moreover, overall numbers and areas of plaques were significantly decreased in whole brains of JAT-administered APP/PS1 mice compared with the level in vehicle treatment groups (Fig. <xref ref-type="fig" rid="Fig2">2e,f</xref>). This tendency was observed not only in the cortex (Fig. <xref ref-type="fig" rid="Fig2">2g,h</xref>), but also in hippocampus (Fig. <xref ref-type="fig" rid="Fig2">2i,j</xref>). The above data clearly demonstrated that JAT administration decreased Aβ plaques in different brain regions of APP/PS1 mice.<fig id="Fig2"><label>Figure 2</label><caption><p>Jatrorrhizine reduces Aβ plaques in the brains of APP/PS1 mice. (<bold>a</bold>) Immunohistochemical analysis of cortical and hippocampal regions of the brains in wild-type (Wt) and APP/PS1 mice after administration. Diffuse plaques in the brain sections were stained by anti-Aβ antibody (clone 6E10, green colour) and anti-GFAP antibody (red colour). Hoechst 33342 (blue colour) was applied for nuclear counterstaining. Scale bars = 200 μm. (<bold>b</bold>) Magnification of one segment of the immunostaining in APP/PS1 group from (<bold>b</bold>) (Scale bars = 200 μm, 100 μm, 50 μm, 20 μm, clockwise respectively). As shown in (<bold>c</bold>), diffuse plaques co-localized with reactive astrocytes in APP/PS1 mouse brains. (<bold>d</bold>) Statistics of GFAP in the brains of each group. (<bold>e–j</bold>) Statistics of Aβ plaques in the brains of each group. Total numbers and areas of Aβ plaques in the whole brains (<bold>e,f</bold>), cortex (<bold>g,h</bold>) and hippocampus (<bold>i,j</bold>). Data information: In (<bold>e–j</bold>), data are presented as mean SEM. <sup>##</sup>P &lt; 0.01, <sup>###</sup>P &lt; 0.001 compared to WT mice, *P ≤ 0.05, **P ≤ 0.01 and ***P ≤ 0.001 (one-way ANOVA followed by Bonferroni’s post hoc comparisons tests).</p></caption><graphic id="d29e652" xlink:href="41598_2019_56149_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec15">
<title>APP/PS1 transgenic mice showed a remarkably different composition of gut microbiota compared to C57BL/6 mice</title>
<sec id="Sec16">
<title>APP/PS1 mice had lower OTUs abundance and alpha diversity compared to C57BL/6 mice</title>
<p id="Par18">To assess the potential correlations between AD and gut microbiota, we sequenced the fecal samples from 6 APP/PS1 and 6 C57BL/6 mice. In total 851,851 raw tags (743,120 clean tags) were obtained from 12 samples with an average of 61927 ± 7037 clean tags. We found the number of operational taxonomic units (OTUs) in APP/PS1 mice was significantly lower (p &lt; 0.001) than that of C57BL/6 mice (Figs. <xref ref-type="fig" rid="Fig3">3a</xref>, <xref ref-type="media" rid="MOESM1">S1a</xref>), indicating a lower gut microbiota abundance in APP/PS1 mice. Alpha diversity reflects the diversity of species within a single sample, with a variety of metrics: Chao1, Ace, Shannon, and Simpson. Alpha diversity was significantly higher in C57BL/6 mice compared to APP/PS1 mice (observed Chao1 index, <italic>p</italic> &lt; <italic>0.01</italic>; Ace index, <italic>p</italic> &lt; <italic>0.001</italic>; Shannon index, <italic>p</italic> &lt; <italic>0.001</italic>) (Figs. <xref ref-type="fig" rid="Fig3">3b</xref>, <xref ref-type="media" rid="MOESM1">S1b–e</xref>). Many studies have pointed out that the high diversity of bacterial flora usually indicates better health status of the host. Analysis of beta diversity using principal coordinate’s analysis (PCoA) and Non-MetricMulti-Dimensional Scaling (NMDS) indicated that the microbiota composition was dramatically different between APP/PS1 and C57BL/6 mice. Figure <xref ref-type="fig" rid="Fig5">5c,d</xref> shows tightly grouped microbiota composition in C57BL/6 mice, while much more scattered in APP/PS1 mice.<fig id="Fig3"><label>Figure 3</label><caption><p>APP/PS1 transgenic mice showed a remarkably different composition of gut microbiota compared to C57BL/6 mice. We sequenced the fecal samples from 6 APP/PS1 and 6 C57BL/6 mice. (<bold>a</bold>) Amounts of operational taxonomic units (OTUs) in APP/PS1 mice and C57BL/6 mice. (<bold>b</bold>) Alpha diversity in C57BL/6 mice and APP/PS1 mice. <italic>(NOTE: The abscissa of this image is sample’s name and the ordinate is the relative abundance percentage. Each color represents a species, and the area of each color represents the relative abundance ratio)</italic>. (<bold>c</bold>) The identity of 97% of OTUs between APP/PS1 and C57BL/6 were measured, and (<bold>d</bold>) showed the amounts of phylum Firmicutes, phylum Bacteroidetes and Tenericutes in APP/PS1 mice and C57BL/6 mice. (<bold>e</bold>) Predictive assessment of the microbial community functional potential (PICRUst) was performed to record differences and changes in the metabolic pathways between APP/PS1 mice and C57BL/6 mice.</p></caption><graphic id="d29e723" xlink:href="41598_2019_56149_Fig3_HTML"></graphic></fig><fig id="Fig4"><label>Figure 4</label><caption><p>The JAT treatment modulated the imbalance of gut microbiota in APP/PS1 transgenic mice. We collected fecal samples of APP/PS1 mice from group JATH, JATL and DONE, and then performed 16S rDNA amplicon sequence. Mean OTU numbers (<bold>a</bold>) and alpha diversities (<bold>b</bold>) of each experimental group were measured. Principal coordinate’s analysis (PCoA) (<bold>c</bold>) and Non-MetricMulti-Dimensional Scaling (NMDS) (<bold>d</bold>) were used to make analysis of beta diversity and showed the microbiota composition among groups. (<bold>e,f</bold>) Unweighted pair-group method with arithmetic mean (UPGMA) based on OTU or phylogenetic was used to show the microbiota of mice feces.</p></caption><graphic id="d29e747" xlink:href="41598_2019_56149_Fig4_HTML"></graphic></fig><fig id="Fig5"><label>Figure 5</label><caption><p>The JAT treatment modulated the imbalance of gut microbiota in APP/PS1 transgenic mice. We collected fecal samples of APP/PS1 mice from group JATH, JATL and DONE, and then performed 16S rDNA amplicon sequence. (<bold>a</bold>) Relative abundance (%) of species within a single sample of all experimental groups. (<bold>b–h</bold>) Statistics in the abundance of some bacteria. Amounts of Phylum Tenericutes (<bold>b</bold>), Bacteroidetes (<bold>c</bold>), phyla Firmicute (<bold>d</bold>), the ratio of Firmicutes and Bacteroidetes (F/B) (<bold>e</bold>), Lactobacillus acidophilus (<bold>f</bold>), Bifidobacterium (<bold>g</bold>) and Faecalibaculum (<bold>h</bold>).</p></caption><graphic id="d29e784" xlink:href="41598_2019_56149_Fig5_HTML"></graphic></fig></p>
</sec>
<sec id="Sec17">
<title>Abundance of certain bacteria is severely changed in APP/PS1 mice</title>
<p id="Par19">The identity of 97% of OTUs was distributed across 9 phyla and there were distinguishable changes between APP/PS1 and C57BL/6 (Fig. <xref ref-type="fig" rid="Fig3">3c</xref>). The amount of phylum <italic>Firmicutes</italic>, which made up the predominant bacterial division, increased and the amount of phylum <italic>Bacteroidetes</italic> and <italic>Tenericutes</italic> dramatically decreased in APP/PS1 mice compare to C57BL/6 mice (Fig. <xref ref-type="fig" rid="Fig3">3d</xref>). In this study, we performed the abundance analyses between the two groups at the level of phylum, class, order, family, genus and species. At a false discovery rate of 5%, we identified 89 differentially abundant taxa within the phylum, class, order, family and genus levels. APP/PS1 transgenic mice also had different abundance of certain gut microbiota compared to C57BL/6 as shown in Table <xref ref-type="table" rid="Tab1">1</xref>. Several taxa were only detected in C57BL/6 mice, but not in APP/PS1 mice and these included phylum <italic>Verrucomicrobiae</italic>, family <italic>Peptostreptococcaceae</italic>, genus <italic>Akkermansia</italic> and <italic>Allobaculum</italic>, indicating C57BL/6 mice had an abundance fecal microbiota (Table <xref ref-type="table" rid="Tab1">1</xref>). <italic>Peptostreptococcaceae</italic> is a beneficial gram-positive bacterium that can synthesize short-chain fatty acids in the intestine that can play an anti-inflammatory role by promoting the production of indole acrylic acid<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. In addition, <italic>Akkermansia</italic> is an important probiotic that can help alleviate obesity and lower blood glucose level<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. The remarkable difference between APP/PS1 and C57BL/6 mice indicated APP/PS1 had a dysbiosis.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Abundance of certain bacteria is severely changed in APP/PS1 mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>P value</th><th>Mean(C57BL6)</th><th>Mean(APP/PS1)</th><th>Log2 fold change</th></tr></thead><tbody><tr><td colspan="5"><bold>Phylum</bold></td></tr><tr><td>Firmicutes</td><td>0.000000</td><td>0.548000</td><td>0.737000</td><td>−0.43</td></tr><tr><td>Bacteroidetes</td><td>0.000200</td><td>0.342000</td><td>0.145000</td><td>1.24</td></tr><tr><td>Tenericutes</td><td>0.001800</td><td>0.023100</td><td>0.000968</td><td>4.58</td></tr><tr><td>Actinobacteria</td><td>0.013600</td><td>0.000984</td><td>0.000082</td><td>3.58</td></tr><tr><td>Cyanobacteria</td><td>0.013900</td><td>0.004410</td><td>0.000208</td><td>4.41</td></tr><tr><td>Verrucomicrobia</td><td>0.018700</td><td>0.007350</td><td>ND.</td><td></td></tr><tr><td>Deferribacteres</td><td>0.039600</td><td>0.011600</td><td>0.033200</td><td>−1.52</td></tr><tr><td colspan="5"><bold>Class</bold></td></tr><tr><td>Clostridia</td><td>0.000000</td><td>0.508000</td><td>0.731000</td><td>−0.53</td></tr><tr><td>Betaproteobacteria</td><td>0.000353</td><td>0.007050</td><td>0.000005</td><td>10.43</td></tr><tr><td>Bacteroidia</td><td>0.000706</td><td>0.342000</td><td>0.145000</td><td>1.24</td></tr><tr><td>Mollicutes</td><td>0.001290</td><td>0.023100</td><td>0.000968</td><td>4.58</td></tr><tr><td>Coriobacteriia</td><td>0.001650</td><td>0.000685</td><td>0.000080</td><td>3.11</td></tr><tr><td>Erysipelotrichia</td><td>0.002590</td><td>0.027100</td><td>0.000485</td><td>5.80</td></tr><tr><td>Epsilonproteobacteria</td><td>0.010700</td><td>0.019000</td><td>0.051600</td><td>−1.44</td></tr><tr><td>Melainabacteria</td><td>0.013700</td><td>0.004410</td><td>0.000208</td><td>4.41</td></tr><tr><td>Alphaproteobacteria</td><td>0.017000</td><td>0.003890</td><td>0.000028</td><td>7.11</td></tr><tr><td>Verrucomicrobiae</td><td>0.018700</td><td>0.007350</td><td>ND.</td><td></td></tr><tr><td>Deferribacteres</td><td>0.038300</td><td>0.011600</td><td>0.033200</td><td>−1.52</td></tr><tr><td colspan="5"><bold>Order</bold></td></tr><tr><td>Bacteroidales</td><td>0.000000</td><td>0.342000</td><td>0.145000</td><td>1.24</td></tr><tr><td>Burkholderiales</td><td>0.000000</td><td>0.007050</td><td>0.000005</td><td>10.43</td></tr><tr><td>Clostridiales</td><td>0.000000</td><td>0.508000</td><td>0.731000</td><td>−0.53</td></tr><tr><td>Mollicutes_RF9</td><td>0.000000</td><td>0.015300</td><td>0.000730</td><td>4.39</td></tr><tr><td>Coriobacteriales</td><td>0.000632</td><td>0.000685</td><td>0.000080</td><td>3.11</td></tr><tr><td>Erysipelotrichales</td><td>0.001110</td><td>0.027100</td><td>0.000485</td><td>5.80</td></tr><tr><td>Campylobacterales</td><td>0.010200</td><td>0.019000</td><td>0.051600</td><td>−1.44</td></tr><tr><td>Gastranaerophilales</td><td>0.012500</td><td>0.004410</td><td>0.000208</td><td>4.41</td></tr><tr><td>Rhodospirillales</td><td>0.015600</td><td>0.003890</td><td>0.000028</td><td>7.11</td></tr><tr><td>Verrucomicrobiales</td><td>0.016700</td><td>0.007350</td><td>ND.</td><td></td></tr><tr><td>Anaeroplasmatales</td><td>0.030900</td><td>0.007610</td><td>0.000003</td><td>11.54</td></tr><tr><td>Deferribacterales</td><td>0.036900</td><td>0.011600</td><td>0.033200</td><td>−1.52</td></tr><tr><td colspan="5"><bold>Family</bold></td></tr><tr><td>Lachnospiraceae</td><td>0.000000</td><td>0.342000</td><td>0.583000</td><td>−0.77</td></tr><tr><td>Alcaligenaceae</td><td>0.000355</td><td>0.007050</td><td>0.000005</td><td>10.43</td></tr><tr><td>Christensenellaceae</td><td>0.000839</td><td>0.000510</td><td>0.000008</td><td>6.05</td></tr><tr><td>Coriobacteriaceae</td><td>0.001100</td><td>0.000685</td><td>0.000080</td><td>3.11</td></tr><tr><td>bacterium</td><td>0.001260</td><td>0.019700</td><td>0.000938</td><td>4.39</td></tr><tr><td>Bacteroidales_S24-7_group</td><td>0.001740</td><td>0.176000</td><td>0.008280</td><td>4.41</td></tr><tr><td>Family_XIII</td><td>0.001900</td><td>0.001650</td><td>0.000557</td><td>1.57</td></tr><tr><td>Prevotellaceae</td><td>0.002350</td><td>0.031900</td><td>0.000839</td><td>5.25</td></tr><tr><td>Erysipelotrichaceae</td><td>0.002520</td><td>0.027100</td><td>0.000485</td><td>5.80</td></tr><tr><td>Peptostreptococcaceae</td><td>0.007900</td><td>0.001180</td><td>ND.</td><td></td></tr><tr><td>Helicobacteraceae</td><td>0.011200</td><td>0.019000</td><td>0.051600</td><td>−1.44</td></tr><tr><td>Rhodospirillaceae</td><td>0.019900</td><td>0.003890</td><td>0.000028</td><td>7.11</td></tr><tr><td>Rs-E47_termite_group</td><td>0.020100</td><td>0.007930</td><td>0.003740</td><td>1.08</td></tr><tr><td>Verrucomicrobiaceae</td><td>0.021200</td><td>0.007350</td><td>ND.</td><td></td></tr><tr><td>Anaeroplasmataceae</td><td>0.033400</td><td>0.007610</td><td>0.000003</td><td>11.54</td></tr><tr><td>Deferribacteraceae</td><td>0.037900</td><td>0.011600</td><td>0.033200</td><td>−1.52</td></tr><tr><td colspan="5"><bold>Genus</bold></td></tr><tr><td>Tyzzerella_3</td><td>0.000013</td><td>0.000010</td><td>0.003250</td><td>−8.35</td></tr><tr><td>Parasutterella</td><td>0.000158</td><td>0.007050</td><td>0.000005</td><td>10.43</td></tr><tr><td>Ruminococcaceae_NK4A214_group</td><td>0.000303</td><td>0.000921</td><td>0.000442</td><td>1.06</td></tr><tr><td>Intestinimonas</td><td>0.000421</td><td>0.000190</td><td>0.000640</td><td>−1.75</td></tr><tr><td>Parabacteroides</td><td>0.000513</td><td>0.005240</td><td>0.000208</td><td>4.65</td></tr><tr><td>Ruminococcaceae_UCG-010</td><td>0.000632</td><td>0.001060</td><td>0.000023</td><td>5.52</td></tr><tr><td>Rikenellaceae_RC9_gut_group</td><td>0.000737</td><td>0.009720</td><td>0.002680</td><td>1.86</td></tr><tr><td>Lachnospiraceae_UCG-001</td><td>0.000829</td><td>0.013700</td><td>0.058000</td><td>−2.08</td></tr><tr><td>Coriobacteriaceae_UCG-002</td><td>0.001550</td><td>0.000349</td><td>ND.</td><td></td></tr><tr><td>Enterorhabdus</td><td>0.001640</td><td>0.000335</td><td>0.000080</td><td>2.07</td></tr><tr><td>Alloprevotella</td><td>0.001960</td><td>0.025900</td><td>0.000495</td><td>5.71</td></tr><tr><td>Rikenella</td><td>0.002750</td><td>0.002670</td><td>0.007560</td><td>−1.50</td></tr><tr><td>Faecalibaculum</td><td>0.002870</td><td>0.000601</td><td>0.000008</td><td>6.29</td></tr><tr><td>Christensenellaceae_R-7_group</td><td>0.002960</td><td>0.000332</td><td>0.000008</td><td>5.43</td></tr><tr><td>Ruminococcaceae_UCG-014</td><td>0.003070</td><td>0.048400</td><td>0.008800</td><td>2.46</td></tr><tr><td>[Eubacterium]_brachy_group</td><td>0.003550</td><td>0.000162</td><td>0.000044</td><td>1.89</td></tr><tr><td>Anaerotruncus</td><td>0.004510</td><td>0.008920</td><td>0.019400</td><td>−1.12</td></tr><tr><td>Prevotellaceae_UCG-001</td><td>0.004640</td><td>0.002800</td><td>0.000323</td><td>3.12</td></tr><tr><td>Family_XIII_AD3011_group</td><td>0.004920</td><td>0.000149</td><td>ND.</td><td></td></tr><tr><td>Acetitomaculum</td><td>0.005040</td><td>0.000253</td><td>0.001670</td><td>−2.72</td></tr><tr><td>Ruminococcaceae_UCG-003</td><td>0.005880</td><td>0.000760</td><td>0.000082</td><td>3.21</td></tr><tr><td>Ruminococcaceae_UCG-005</td><td>0.007540</td><td>0.000616</td><td>0.000072</td><td>3.09</td></tr><tr><td>Lachnospiraceae_UCG-008</td><td>0.007840</td><td>0.000010</td><td>0.000098</td><td>−3.33</td></tr><tr><td>Helicobacter</td><td>0.008090</td><td>0.019000</td><td>0.051600</td><td>−1.44</td></tr><tr><td>Roseburia</td><td>0.011500</td><td>0.011000</td><td>0.022500</td><td>−1.03</td></tr><tr><td>Lachnospiraceae_FCS020_group</td><td>0.012400</td><td>0.001510</td><td>0.000347</td><td>2.12</td></tr><tr><td>Ruminiclostridium</td><td>0.013700</td><td>0.007910</td><td>0.016200</td><td>−1.03</td></tr><tr><td>Turicibacter</td><td>0.013800</td><td>0.013800</td><td>0.000049</td><td>8.15</td></tr><tr><td>Tyzzerella</td><td>0.014800</td><td>0.004590</td><td>0.000993</td><td>2.21</td></tr><tr><td>Akkermansia</td><td>0.016800</td><td>0.007350</td><td>ND.</td><td></td></tr><tr><td>[Eubacterium]_xylanophilum_group</td><td>0.017000</td><td>0.011800</td><td>0.002470</td><td>2.26</td></tr><tr><td>Ruminococcus_1</td><td>0.018000</td><td>0.003710</td><td>0.000093</td><td>5.32</td></tr><tr><td>Allobaculum</td><td>0.025600</td><td>0.000922</td><td>ND.</td><td></td></tr><tr><td>Anaeroplasma</td><td>0.026100</td><td>0.007610</td><td>0.000003</td><td>11.54</td></tr><tr><td>[Eubacterium]_nodatum_group</td><td>0.028300</td><td>0.000721</td><td>0.000054</td><td>3.74</td></tr><tr><td>Mucispirillum</td><td>0.030800</td><td>0.011600</td><td>0.033200</td><td>−1.52</td></tr><tr><td>Ruminococcaceae_UCG-013</td><td>0.035100</td><td>0.002350</td><td>0.000062</td><td>5.25</td></tr><tr><td>bacterium</td><td>0.039200</td><td>0.354000</td><td>0.278000</td><td>0.35</td></tr><tr><td>Lachnospiraceae_NK4A136_group</td><td>0.042100</td><td>0.164000</td><td>0.228000</td><td>−0.48</td></tr><tr><td>Lachnospiraceae_UCG-010</td><td>0.042100</td><td>0.000073</td><td>0.000218</td><td>−1.58</td></tr><tr><td>Acetatifactor</td><td>0.044900</td><td>0.000423</td><td>0.002780</td><td>−2.72</td></tr><tr><td>Prevotellaceae_NK3B31_group</td><td>0.047400</td><td>0.002020</td><td>ND,</td><td></td></tr><tr><td>Candidatus_Stoquefichus</td><td>0.047800</td><td>0.001140</td><td>0.000074</td><td>3.94</td></tr><tr><td colspan="5"><bold>Species</bold></td></tr><tr><td>rumen_bacterium</td><td>0.009250</td><td>0.009670</td><td>ND.</td><td></td></tr><tr><td>bacterium</td><td>0.016500</td><td>0.964000</td><td>0.980000</td><td>−0.02</td></tr></tbody></table><table-wrap-foot><p>Note: ND. NOT Detected.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec18">
<title>Functional analysis of APP/PS1 mice and C57BL/6 mice</title>
<p id="Par20">We used a predictive assessment of the microbial community functional potential (PICRUst), and then compared different abundances of KOs through STAMP to study differences and changes in the metabolic pathways between APP/PS1 mice and C57BL/6 mice. C57BL/6 mice had more genes involved in the metabolic pathways, particularly in endocrine and metabolic disease, translation and drug resistance (Welch’s t-test, <italic>p</italic> &lt; <italic>0.001</italic>). However, genes associated with cell motility, environment adaptation, xenobiotics biodegradation and metabolism, were more abundance in APP/PS1 (Welch’s t-test, <italic>p</italic> &lt; <italic>0.001</italic>) (Fig. <xref ref-type="fig" rid="Fig3">3e</xref>).</p>
</sec>
</sec>
<sec id="Sec19">
<title>The JAT treatment modulated the imbalance of gut microbiota in APP/PS1 transgenic mice</title>
<sec id="Sec20">
<title>JAT administration improved the OTUs abundance and alpha diversity of APP/PS1 mice</title>
<p id="Par21">Donepezil is a clinical drug inhibited the activity of acetylcholinesterase and butyrylcholinesterase, thus enhancing cognitive function<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Here, donepezil was used as a positive control, to evaluate the anti-aging effect and regulating effect on intestinal microbiota. We collected fecal samples of APP/PS1 mice from group JATH, JATL and DONE, and then performed 16S rDNA amplicon sequence.</p>
<p id="Par22">When compared to mice in saline administered control APP/PS1 group, the high dose JAT (JATH) and DONE treatment have higher mean OTU numbers and alpha diversities (Figs. <xref ref-type="fig" rid="Fig4">4a,b</xref>, <xref ref-type="media" rid="MOESM1">S1</xref>), indicating that JAT administration can improve the abundance of gut microbiota. The mice fecal microbiota was generally clustered consistently within groups. PCoA and NMDS indicated that microbiota of the mice that received JAT administration were more similar among C57BL/6 than APP/PS1 mice. This finding implies JAT treatment may restore the gut microbiota balance in APP/PS1 mice (Fig. <xref ref-type="fig" rid="Fig4">4c,d</xref>). Sample hierarchical clustering using unweighted pair-group method with arithmetic mean (UPGMA) based on OTU or phylogenetic showed that the microbiota of mice feces was different among mouse strains and groups. The microbiota in C57BL/6 mice and group JATH showed greater similarity with closer matrix distances than with samples from other groups (Fig. <xref ref-type="fig" rid="Fig4">4e,f</xref>).</p>
</sec>
<sec id="Sec21">
<title>Abundance of some bacteria is also changed through JAT administration</title>
<p id="Par23">Distinct taxonomic patterns discriminate APP/PS1 mice from C57BL/6 mice, while high dose JAT and DONE administration blurs the difference (Fig. <xref ref-type="fig" rid="Fig5">5a</xref>). JATH, JATL as well as DONE administered APP/PS1 mice had elevated the amount of Phylum <italic>Tenericutes</italic> and <italic>Bacteroidetes</italic> compared to saline treated group (Fig. <xref ref-type="fig" rid="Fig5">5b,c</xref>). The most predominant phyla <italic>Firmicutes</italic> was downregulated in JATH (mouse strain) groups compared to APP/PS1 saline group. Low dose JAT administration also down-regulated phyla <italic>Firmicute</italic>, although it was not significant (Fig. <xref ref-type="fig" rid="Fig5">5d</xref>). The ratio of Firmicutes and Bacteroidetes (F/B), an important microbiological indicator used to measure obesity, is an independent risk factor for Alzheimer’s disease. Individuals with a high obesity index have greater F/B values. APP/PS1 mice have greater F/B ratio than C57BL/6 mice (p &lt; 0.001). Our results, as shown in Fig. <xref ref-type="fig" rid="Fig5">5e</xref>, revealed that JAT treatment can lower the F/B ratio.</p>
<p id="Par24"><italic>Lactobacillus acidophilus</italic> and <italic>Bifidobacterium</italic> were the main probiotic in intestine, which play crucial roles in the maintenance of gastrointestinal micro-ecological balance<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. APP/PS1 mice showed less quantities of these two beneficial microbes compared to C57BL/6 mice, while JATH treatment elevated their amount (Fig. <xref ref-type="fig" rid="Fig5">5f,g</xref>). <italic>Faecalibaculum</italic> is a putative anti-inflammatory taxon colonizing in intestine<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, and our data showed that its amount was higher in the JATH treated and C57BL/6 mice compared to the APP/PS1 control group that received saline (Fig. <xref ref-type="fig" rid="Fig5">5h</xref>).</p>
</sec>
<sec id="Sec22">
<title>Functional analysis and co-expression analysis of all mice</title>
<p id="Par25">The functional genes involved in the metabolic pathway differed significantly between C57BL/6 and APP/PS1 mice. In addition, we also observed that these genes were also altered in mice that were treated with drugs (Fig. <xref ref-type="media" rid="MOESM1">S2</xref>). SparCC was used for correlation analyses in order to elucidate the complex inner workings of microbial communities according to the abundance and variation of each genus in each sample. Figure <xref ref-type="fig" rid="Fig6">6</xref> shows the network diagram of genera with a correlation coefficient greater than 0.1. In this study, we observed a strong correlation among some genus, within genus <italic>Helicobacter</italic> and <italic>Mucispirillum</italic> show the strongest positive correlation <italic>(r</italic> = <italic>0.886)</italic>, and <italic>Bacterium</italic> and <italic>Ruminococcus_1</italic> had the strongest negative correlation in this study <italic>(r</italic> = −<italic>0.767)</italic>.<fig id="Fig6"><label>Figure 6</label><caption><p>Functional Analysis and co-expression analysis of all mice. SparCC was used for correlation analyses and the image revealed the network diagram of genera with a correlation coefficient greater than 0.1.</p></caption><graphic id="d29e2488" xlink:href="41598_2019_56149_Fig6_HTML"></graphic></fig></p>
</sec>
</sec>
</sec>
<sec id="Sec23" sec-type="discussion">
<title>Discussion</title>
<p id="Par26">AD is the most common neurodegenerative disorder with impaired cognition<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. It is generally considered that both environmental and genetic factors are involved in AD pathogenesis. Genes associated with amyloid metabolism, tau phosphorylation, lipids transport, cell migration and inflammatory pathways were considered the most susceptible genes in AD<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. While some non-genetic environmental factors such as exposure to hazardous materials, lifestyle and physical status were thought to be more important than genetic factors to cause AD, increasing evidence suggests that the etiology of AD could also derive from the gut microbiota<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>.</p>
<p id="Par27">Our previous studies have shown that JAT had significant protective effects against H<sub>2</sub>O<sub>2</sub>-induced injury on nerve cells<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>and against Aβ<sub>25–35</sub>-induced neurotoxicity on rat cortical neurons via its antioxidative potential. Therefore, in light of these findings, we are committed to unraveling the potential therapeutic effect of JAT on AD through <italic>in vivo</italic> experiments. In the current study, at the age of 3 months, the APP/PS1 mice were treated with JAT for 24 weeks, followed by behavioral evaluation using the Morris water maze. In order to assess the effectiveness of JAT in AD, Donepezil hydrochloride was selected as the positive control in behavioral tests. JAT improved the spatial learning and spatial memory abilities, as reflected by acquisition and probe trials of the Morris water maze. However, the mechanisms by which these beneficial effects of JAT are utilizing on Alzheimer’s disease are still enigmatic. Previous research reported that Aβ plaques can be divided into diffuse and dense-core plaques. Differing from dense-core plaques, diffuse plaques are incapable of being stained by ThS due to the lack of a special aggregated β-sheet structure<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>, which is present in dense-core plaques. We performed the immunostaining in the mice brains from each group after undergoing behavioral test. Microscopic observations revealed that JAT treatment significantly reduced Aβ plaques in the cortex and hippocampus of APP/PS1 mice.</p>
<p id="Par28">Donepezil is a long-acting drug inhibited the activity of acetylcholinesterase<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, and thus enhances cognitive function. It was widely used as the positive control in AD models<sup><xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR44">44</xref></sup>. Results in this study supported that donepezil treatment ameliorated learning and memory deficits in APP/PS1 transgenic mice, which was consistent with previous research<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. At the same time, we also observed that donepezil treatment regulated abundance of some bacteria such as <italic>Tenericutes</italic>, <italic>Bacteroidetes</italic> as well as <italic>Firmicutes</italic>. However, as an acetylcholinesterase inhibitor (AChE), donepezil can cause gastrointestinal side effects, such as nausea, vomiting and other diseases<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, while the recommended doses of JAT seem have fewer side effects. On the other hand, the donepezil treatment reduced the abundance of several OTUs species of Bifidobacterium and Lactobacillus, while JAT treatment increased the corresponding abundance. Bifidobacterium and Lactobacillus are both short-chain fatty acids (SCFAs) -producing strains in the intestinal tract, and various studies have shown that the gut microbiota benefits humans through SCFA production, and the lack of SCFA production is associated with diseases<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Therefore, we proposed that, compared with the Jatrorrhizine treatment, donepezil might result in an imbalance of gut microbiota.</p>
<p id="Par29">To the best of our knowledge, the present study is the first one to evaluate the effect of JAT on gut microbiota in the APP/PS1 mouse model of Alzheimer’s disease. We showed APP/PS1 mice had less gut microbiota compared to C57BL6 mice. The number of OTUs and alpha-diversity were in a significantly lower level in APP/PS1 mice, a finding which was consistent with some other studies on gut microbiota between AD mouse model and normal controls<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Furthermore, JAT treatment elevated the alpha diversity and OTU numbers in APP/PS1 mice. In respect of gut microbiota composition, phyla <italic>Bacteroidetes</italic> and <italic>Firmicutes</italic> are dominant divisions of gut flora<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. In our study, the number of phyla <italic>Bacteroidetes</italic> was decreased while that of phyla <italic>Firmicutes</italic> was more abundant in APP/PS1 mice compared to C57BL/6 mice. Interestingly, we discovered that JAT administration reversed the phenotype. Other reports also showed that amount of <italic>Firmicutes</italic> was increased while <italic>Bacteroidetes</italic> were decreased in the 5xFAD mouse model when compared to non-transgenic 9-week-old wild-type littermates<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. In another AD mouse model, the proportion of <italic>Bacteroidetes</italic> and <italic>Firmicutes</italic> between APP/PS1 mice and WT are opposite, and showed that the ratio of <italic>Bacteroidetes</italic> to <italic>Firmicutes</italic> increased with age<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. These findings may indicate that the gut microbiota varies from model to model in AD, and this variation may be related to varying ages of the mice as well. Further investigation is needed to understand the underlying mechanism of the diverse distribution of gut microbiota.</p>
<p id="Par30">Studies have found that beneficial bacteria can reduce stress and anxiety responses, reduce repetitive behaviors, and improve cognitive function and communication in animals<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Interestingly, we found that JAT treatment enriched the amounts of beneficial bacteria, such as <italic>Faecalibaculum, Lactobacillus acidophilus</italic> and <italic>Bifidobacterium</italic>. The fact that JAT treatment elevated the alpha diversity, OTU numbers and gut microbiota composition, indicates that JAT administration can ameliorate microecology dysbiosis in APP/PS1 mice. Taking all data from the previous studies into consideration, the evidence herein strongly suggests that JAT can improve the learning and memory capabilities in APP/PS1 mice possibly by regulating the intestinal flora, in addition to its anti-oxidative stress effects <italic>in vivo</italic>.</p>
<p id="Par31">Several pharmacological studies indicated that jatrorrhizine has various bioactivities, such as antioxidant, low host toxicity and highly potent antimicrobial activity<sup><xref ref-type="bibr" rid="CR51">51</xref>–<xref ref-type="bibr" rid="CR53">53</xref></sup>. E-selectin is one of the leukocyte adhesion molecules that can cause endothelial cell dysfunction and increased permeability, which may eventually lead to the dysbiosis of gut microbiome. While in one study<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>, Jatrorrhizine was proved to significantly suppress the inflammatory factor E-selectin as well as TNF-alpha expression secreted by RIMECs, and finally inhibit the the occurrence and development of inflammatory response. Besides, jatrorrhizine has also been shown to reduce blood glucose levels in alloxan diabetic mice and demonstrate acetylcholinesterase inhibitory properties<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. In addition, jatrorrhizine was reported to regulate the contractions of gastrointestinal smooth muscles by activation of acetylcholine receptors<sup><xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>. Furthermore, several bacterial species, including Staphylococcus aureus, are capable of producing amyloid fibers<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>, Yu <italic>et al</italic>. studied major single components of Radix Tinosporae, and indicated that alkaloids, such as palmatine and jatrorrhizine, might play main antimicrobial roles on Staphylococcus aureus<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Taking these factors into account, JAT might balance the gut microbiota through the above channels. In this case, further research is necessary to fully elucidate the molecular mechanisms.</p>
<p id="Par32">The gut microbiota-brain axis theory suggests that there is a crosstalk between gastrointestinal microbiota and its human host. Growing evidence has led to the recognition that secretory or degradation products of human microbes play pivotal roles in the etiology of many human diseases. An interesting study carried out by Uemura N and his coworkers provide direct evidence to show that Parkinson pathogens, different forms of α-synuclein, if inoculated into the mouse gastrointestinal tract, could spread from the gastrointestinal tract to the brain via the vagal nerve in rats<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. A clinical matched-cohort study also implied a potential protective effect of truncal vagotomy against the development of Parkinson Disease<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. It is suggested vagus nerve maybe a direct channel for substance transporting between brain and gut. It has been reported that vagus activity affects neurogenesis and brain-derived neurotrophic factor (BDNF) mRNA expression in adult hippocampus<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. Research has showed that one of the primary neurotransmitters used by the vagus nerve is acetylcholine<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> and the vagal innervation may modulate the intestinal microenvironment by determining the cholinergic tone in the enteric nervous system<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Coincidentally, one more study reported the enteric nervous system can amplify the vagus nerve to induce a substantial release of ACh in the intestinal microenvironment to regulate the immune response<sup><xref ref-type="bibr" rid="CR64">64</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup>. Crumeyrolle-Arias M <italic>et al</italic>. showed that bidirectional interaction between the gut–brain axis and the microbiota promotes communication between the humoral, neurological, immune and endocrine systems<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. AD mouse showed lower gut microbiota diversities and gut microbiota was reported to regulate host immunity and affect Aβ amyloidosis<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. However, much remains to be illuminated about the mechanisms and effects of the interaction between the nervous and gastrointestinal systems.</p>
<p id="Par33">Generally, bacterial interventions in the intestine, including oral microbiome, fecal microbiota transplantation and antibiotic or probiotic administration are often used to explore the effect of gut microbiota on host’s behavior and brain physiology. For instance, in one study, <italic>Enterobacteria</italic> infection exacerbated progression of AD by promoting immune hemocyte recruitment to the brain in an AD Drosophila model<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. Germ-free APP/PS1 transgenic mice exhibited reduced Aβ deposition in brain compared to specific pathogen free mice, while colonization of Germ-free APP/PS1 mice with microbiota increases Aβ pathology<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Probiotic administration on 3xTg-AD mice modifies intestinal microbiota and counteracts cognitive decline and brain damage<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. These <italic>in vivo</italic> microbiota reconstruction experiments provide new insights into further prevention and treatment of AD.</p>
</sec>
<sec id="Sec24" sec-type="conclusion">
<title>Conclusion</title>
<p id="Par34">In summary, the current study demonstrated that APP/PS1 mice display gut dysbiosis, treatment with JAT improved hippocampal contextual memory and altered the abundance of some specific gut microbiota such as the most predominant phylum Firmicutes, Bacteroidetes and Lactobacillus as well as F/B ratio in APP/PS1 mice. This may provide a therapeutic way to balance the gut dysbiosis in AD patients.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec25">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2019_56149_MOESM1_ESM.pdf"><caption><p>The JAT treatment modulated the imbalance of gut microbiota in APP/PS1 transgenic mice.</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>These authors contributed equally: Sheng Wang and Wei Jiang.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p>is available for this paper at 10.1038/s41598-019-56149-9.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>This work was supported by Natural Science Foundation of Guangdong Province (No. 2015A030313066, 2015A030310251, 2017A030313904, 2018A030310643), Medical Scientific Research Foundation of Guangdong Province (No. A2016618), Administration of Traditional Chinese Medicine of Guangdong Province (No. 20162156), Science and Technology Foundation of Shenzhen City (No. JCYJ20170818142019191), National Natural Science Foundation of China (No. 81501093), Science and Technology Planning Project of Guangdong Province (No. 2014A020212622).</p>
</ack>
<notes notes-type="author-contribution">
<title>Author contributions</title>
<p>Conceptualization, Sheng Wang, Tao Luo and Hua-Qiao Wang; Data curation, Sheng Wang and Wei Jiang; Formal analysis, Sheng Wang, Wei Jiang, Ting Ouyang and Xiu-Yin Shen; Funding acquisition, Tao Luo, Wei Jiang and Hua-Qiao Wang; Investigation, Sheng Wang; Methodology, Sheng Wang and Fen Wang; Resources, Yu-hua Qu and Min Zhang; Software, Wei Jiang, Ting Ouyang; Supervision, Tao Luo and Hua-Qiao Wang; Writing – original draft, Sheng Wang; Writing – review &amp; editing, Tao Luo. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="data-availability">
<title>Data availability</title>
<p>16S rDNA amplicon sequencing data were submitted to the NCBI SRA database, accession number PRJNA590832. The datasets supporting the conclusions of this article are included within the article.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par35">The authors declare no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendelsohn</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Larrick</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Cellular Senescence as the Key Intermediate in Tau-Mediated Neurodegeneration</article-title>
<source/>Rejuvenation Res.
          <year>2018</year>
<volume>21</volume>
<fpage>572</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="doi">10.1089/rej.2018.2155</pub-id>
<pub-id pub-id-type="pmid">30489222</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira-Vieira</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Guimaraes</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease: Targeting the Cholinergic System</article-title>
<source/>Curr Neuropharmacol.
          <year>2016</year>
<volume>14</volume>
<fpage>101</fpage>
<lpage>115</lpage>
<pub-id pub-id-type="doi">10.2174/1570159X13666150716165726</pub-id>
<pub-id pub-id-type="pmid">26813123</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogt</surname>
<given-names>NM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiome alterations in Alzheimer’s disease</article-title>
<source/>Sci Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>13537</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-13601-y</pub-id>
<pub-id pub-id-type="pmid">29051531</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forslund</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota</article-title>
<source/>Nature.
          <year>2015</year>
<volume>528</volume>
<fpage>262</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1038/nature15766</pub-id>
<pub-id pub-id-type="pmid">26633628</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>VB</given-names>
</name>
</person-group>
<article-title>The role of the microbiome in human health and disease: an introduction for clinicians</article-title>
<source/>Bmj.
          <year>2017</year>
<volume>356</volume>
<fpage>j831</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.j831</pub-id>
<pub-id pub-id-type="pmid">28298355</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Metagenome-wide association studies: fine-mining the microbiome</article-title>
<source/>Nat Rev Microbiol.
          <year>2016</year>
<volume>14</volume>
<fpage>508</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro.2016.83</pub-id>
<pub-id pub-id-type="pmid">27396567</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navab-Moghadam</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The association of type II diabetes with gut microbiota composition</article-title>
<source/>Microb Pathog.
          <year>2017</year>
<volume>110</volume>
<fpage>630</fpage>
<lpage>636</lpage>
<pub-id pub-id-type="doi">10.1016/j.micpath.2017.07.034</pub-id>
<pub-id pub-id-type="pmid">28739439</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill-Burns</surname>
<given-names>EM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome</article-title>
<source/>Mov Disord.
          <year>2017</year>
<volume>32</volume>
<fpage>739</fpage>
<lpage>749</lpage>
<pub-id pub-id-type="doi">10.1002/mds.26942</pub-id>
<pub-id pub-id-type="pmid">28195358</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aho</surname>
<given-names>VTE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota in Parkinson’s disease: Temporal stability and relations to disease progression</article-title>
<source/>EBioMedicine.
          <year>2019</year>
<volume>44</volume>
<fpage>691</fpage>
<lpage>707</lpage>
<pub-id pub-id-type="doi">10.1016/j.ebiom.2019.05.064</pub-id>
<pub-id pub-id-type="pmid">31221587</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wing</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Kremenchutzky</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?</article-title>
<source/>Benef Microbes.
          <year>2019</year>
<volume>10</volume>
<fpage>27</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.3920/BM2018.0029</pub-id>
<pub-id pub-id-type="pmid">30525949</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pulikkan</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders</article-title>
<source/>Microb Ecol.
          <year>2018</year>
<volume>76</volume>
<fpage>1102</fpage>
<lpage>1114</lpage>
<pub-id pub-id-type="doi">10.1007/s00248-018-1176-2</pub-id>
<pub-id pub-id-type="pmid">29564487</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Syeda</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer’s Disease</article-title>
<source/>J Alzheimers Dis.
          <year>2018</year>
<volume>66</volume>
<fpage>1657</fpage>
<lpage>1682</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-180556</pub-id>
<pub-id pub-id-type="pmid">30475761</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The Gut Microbiota and Alzheimer’s Disease</article-title>
<source/>J Alzheimers Dis.
          <year>2017</year>
<volume>58</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-161141</pub-id>
<pub-id pub-id-type="pmid">28372330</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brandscheid</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer’s Mouse Model</article-title>
<source/>J Alzheimers Dis.
          <year>2017</year>
<volume>56</volume>
<fpage>775</fpage>
<lpage>788</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-160926</pub-id>
<pub-id pub-id-type="pmid">28035935</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pasini</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of chronic exercise on gut microbiota and intestinal barrier in human with type 2 diabetes</article-title>
<source/>Minerva Med.
          <year>2019</year>
<volume>110</volume>
<fpage>3</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.23736/S0026-4806.18.05589-1</pub-id>
<pub-id pub-id-type="pmid">30667205</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gastrointestinal inflammation by gut microbiota disturbance induces memory impairment in mice</article-title>
<source/>Mucosal Immunol.
          <year>2018</year>
<volume>11</volume>
<fpage>369</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="doi">10.1038/mi.2017.49</pub-id>
<pub-id pub-id-type="pmid">28612842</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoban</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Behavioural and neurochemical consequences of chronic gut microbiota depletion during adulthood in the rat</article-title>
<source/>Neuroscience.
          <year>2016</year>
<volume>339</volume>
<fpage>463</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.10.003</pub-id>
<pub-id pub-id-type="pmid">27742460</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffman</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Age Drives Distortion of Brain Metabolic, Vascular and Cognitive Functions, and the Gut Microbiome</article-title>
<source/>Front Aging Neurosci.
          <year>2017</year>
<volume>9</volume>
<fpage>298</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2017.00298</pub-id>
<pub-id pub-id-type="pmid">28993728</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harach</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota</article-title>
<source/>Sci Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>41802</fpage>
<pub-id pub-id-type="doi">10.1038/srep41802</pub-id>
<pub-id pub-id-type="pmid">28176819</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>HY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Corrigendum: EPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-beta oligomers and plaques</article-title>
<source/>Nat Commun.
          <year>2016</year>
<volume>7</volume>
<fpage>10755</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms10755</pub-id>
<pub-id pub-id-type="pmid">26877163</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Reducing Abeta load and tau phosphorylation: Emerging perspective for treating Alzheimer’s disease</article-title>
<source/>Eur J Pharmacol.
          <year>2015</year>
<volume>764</volume>
<fpage>571</fpage>
<lpage>581</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2015.07.043</pub-id>
<pub-id pub-id-type="pmid">26209363</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Jatrorrhizine Protects Against Okadaic Acid Induced Oxidative Toxicity Through Inhibiting the Mitogen-Activated Protein Kinases Pathways in HT22 Hippocampal Neurons</article-title>
<source/>CNS Neurol Disord Drug Targets.
          <year>2015</year>
<volume>14</volume>
<fpage>1334</fpage>
<lpage>1342</lpage>
<pub-id pub-id-type="doi">10.2174/1871527314666150821104455</pub-id>
<pub-id pub-id-type="pmid">26295822</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Protective Effect of Jatrorrhizine Against Oxidative Stress in Primary Rat Cortical Neurons</article-title>
<source/>CNS Neurol Disord Drug Targets.
          <year>2017</year>
<volume>16</volume>
<fpage>617</fpage>
<lpage>623</lpage>
<pub-id pub-id-type="pmid">27401065</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer’s Disease: A Randomized Controlled Trial</article-title>
<source/>J Alzheimers Dis.
          <year>2017</year>
<volume>56</volume>
<fpage>1495</fpage>
<lpage>1504</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-161117</pub-id>
<pub-id pub-id-type="pmid">28157100</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castelino</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Optimisation of methods for bacterial skin microbiome investigation: primer selection and comparison of the 454 versus MiSeq platform</article-title>
<source/>BMC Microbiol.
          <year>2017</year>
<volume>17</volume>
<fpage>23</fpage>
<pub-id pub-id-type="doi">10.1186/s12866-017-0927-4</pub-id>
<pub-id pub-id-type="pmid">28109256</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hahn</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum</article-title>
<source/>J Microbiol Methods.
          <year>2016</year>
<volume>130</volume>
<fpage>95</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.mimet.2016.09.002</pub-id>
<pub-id pub-id-type="pmid">27609714</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isaiah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Parambeth</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lidbury</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Suchodolski</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>The fecal microbiome of dogs with exocrine pancreatic insufficiency</article-title>
<source/>Anaerobe.
          <year>2017</year>
<volume>45</volume>
<fpage>50</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2017.02.010</pub-id>
<pub-id pub-id-type="pmid">28223257</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alshawaqfeh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bashaireh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Serpedin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Suchodolski</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Reliable Biomarker discovery from Metagenomic data via RegLRSD algorithm</article-title>
<source/>BMC Bioinformatics.
          <year>2017</year>
<volume>18</volume>
<fpage>328</fpage>
<pub-id pub-id-type="doi">10.1186/s12859-017-1738-1</pub-id>
<pub-id pub-id-type="pmid">28693478</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ziebell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>An</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>An informative approach on differential abundance analysis for time-course metagenomic sequencing data</article-title>
<source/>Bioinformatics.
          <year>2017</year>
<volume>33</volume>
<fpage>1286</fpage>
<lpage>1292</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btw597</pub-id>
<pub-id pub-id-type="pmid">28057680</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parks</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Tyson</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Hugenholtz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Beiko</surname>
<given-names>RG</given-names>
</name>
</person-group>
<article-title>STAMP: statistical analysis of taxonomic and functional profiles</article-title>
<source/>Bioinformatics.
          <year>2014</year>
<volume>30</volume>
<fpage>3123</fpage>
<lpage>3124</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btu494</pub-id>
<pub-id pub-id-type="pmid">25061070</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alm</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<article-title>Inferring correlation networks from genomic survey data</article-title>
<source/>PLoS Comput Biol.
          <year>2012</year>
<volume>8</volume>
<fpage>e1002687</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1002687</pub-id>
<pub-id pub-id-type="pmid">23028285</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bennett</surname>
<given-names>RE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enhanced Tau Aggregation in the Presence of Amyloid beta</article-title>
<source/>Am J Pathol.
          <year>2017</year>
<volume>187</volume>
<fpage>1601</fpage>
<lpage>1612</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajpath.2017.03.011</pub-id>
<pub-id pub-id-type="pmid">28500862</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Changes of intranetwork and internetwork functional connectivity in Alzheimer’s disease and mild cognitive impairment</article-title>
<source/>J Neural Eng.
          <year>2016</year>
<volume>13</volume>
<fpage>046008</fpage>
<pub-id pub-id-type="doi">10.1088/1741-2560/13/4/046008</pub-id>
<pub-id pub-id-type="pmid">27247279</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kageyama</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Amyloid beta toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques</article-title>
<source/>Sci Rep.
          <year>2018</year>
<volume>8</volume>
<fpage>16895</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-35004-3</pub-id>
<pub-id pub-id-type="pmid">30442978</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Nievas</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Serrano-Pozo</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Deciphering the Astrocyte Reaction in Alzheimer’s Disease</article-title>
<source/>Front Aging Neurosci.
          <year>2018</year>
<volume>10</volume>
<fpage>114</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2018.00114</pub-id>
<pub-id pub-id-type="pmid">29922147</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wlodarska</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation</article-title>
<source/>Cell Host Microbe.
          <year>2017</year>
<volume>22</volume>
<fpage>25</fpage>
<lpage>37.e26</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2017.06.007</pub-id>
<pub-id pub-id-type="pmid">28704649</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chelakkot</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions</article-title>
<source/>Exp Mol Med.
          <year>2018</year>
<volume>50</volume>
<fpage>e450</fpage>
<pub-id pub-id-type="doi">10.1038/emm.2017.282</pub-id>
<pub-id pub-id-type="pmid">29472701</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<mixed-citation publication-type="other">Agunloye, O. M. &amp; Oboh, G. Modulatory effect of caffeic acid on cholinesterases inhibitory properties of donepezil. <italic>J Complement Integr Med</italic>. <bold>15</bold> (2017).</mixed-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>MS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A probiotic combination attenuates experimental colitis through inhibition of innate cytokine production</article-title>
<source/>Benef Microbes.
          <year>2017</year>
<volume>8</volume>
<fpage>231</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.3920/BM2016.0031</pub-id>
<pub-id pub-id-type="pmid">28008786</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<mixed-citation publication-type="other">La Rosa, F. <italic>et al</italic>. The Gut-Brain Axis in Alzheimer’s Disease and Omega-3. A Critical Overview of Clinical Trials. <italic>Nutrients</italic>. <bold>10</bold> (2018).</mixed-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-beta Protein Precursor Transgenic Mice</article-title>
<source/>J Alzheimers Dis.
          <year>2017</year>
<volume>56</volume>
<fpage>743</fpage>
<lpage>761</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-161027</pub-id>
<pub-id pub-id-type="pmid">28059792</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathological Changes in APP/PS-1 Transgenic Mouse Models of Alzheimer’s Disease Treated with Ganoderma Lucidum Preparation</article-title>
<source/>Zhongguo Yi Xue Ke Xue Yuan Xue Bao.
          <year>2017</year>
<volume>20</volume>
<issue>39(4)</issue>
<fpage>552</fpage>
<lpage>561</lpage>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>ZX</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>AN</given-names>
</name>
</person-group>
<article-title>Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study</article-title>
<source/>Exp Gerontol.
          <year>2016</year>
<volume>84</volume>
<fpage>88</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1016/j.exger.2016.09.003</pub-id>
<pub-id pub-id-type="pmid">27612601</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puri</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Vardigan</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Kuduk</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Uslaner</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer’s disease mouse model</article-title>
<source/>Behav Brain Res.
          <year>2015</year>
<volume>287</volume>
<fpage>96</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2015.03.029</pub-id>
<pub-id pub-id-type="pmid">25800972</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>HB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation</article-title>
<source/>Neuroscience.
          <year>2015</year>
<volume>290</volume>
<fpage>530</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.01.058</pub-id>
<pub-id pub-id-type="pmid">25662507</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mimica</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Presecki</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Side effects of approved antidementives</article-title>
<source/>Psychiatr Danub.
          <year>2009</year>
<volume>21</volume>
<fpage>108</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="pmid">19270633</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes</article-title>
<source/>Science.
          <year>2018</year>
<volume>359</volume>
<fpage>1151</fpage>
<lpage>1156</lpage>
<pub-id pub-id-type="doi">10.1126/science.aao5774</pub-id>
<pub-id pub-id-type="pmid">29590046</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xin</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of Oligosaccharides From Morinda officinalis on Gut Microbiota and Metabolome of APP/PS1 Transgenic Mice</article-title>
<source/>Front Neurol.
          <year>2018</year>
<volume>9</volume>
<fpage>412</fpage>
<pub-id pub-id-type="doi">10.3389/fneur.2018.00412</pub-id>
<pub-id pub-id-type="pmid">29962999</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>HF</given-names>
</name>
</person-group>
<article-title>Alzheimer’s Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State</article-title>
<source/>J Alzheimers Dis.
          <year>2017</year>
<volume>56</volume>
<fpage>385</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-160884</pub-id>
<pub-id pub-id-type="pmid">27911317</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders</article-title>
<source/>Cell.
          <year>2013</year>
<volume>155</volume>
<fpage>1451</fpage>
<lpage>1463</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.11.024</pub-id>
<pub-id pub-id-type="pmid">24315484</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slobodnikova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kost’alova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Labudova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kotulova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kettmann</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids</article-title>
<source/>Phytother Res.
          <year>2004</year>
<volume>18</volume>
<fpage>674</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="doi">10.1002/ptr.1517</pub-id>
<pub-id pub-id-type="pmid">15476315</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rackova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Majekova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kost’alova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stefek</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium. Structural aspects</article-title>
<source/>Bioorg Med Chem.
          <year>2004</year>
<volume>12</volume>
<fpage>4709</fpage>
<lpage>4715</lpage>
<pub-id pub-id-type="doi">10.1016/j.bmc.2004.06.035</pub-id>
<pub-id pub-id-type="pmid">15358297</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vollekova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kost’alova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kettmann</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids</article-title>
<source/>Phytother Res.
          <year>2003</year>
<volume>17</volume>
<fpage>834</fpage>
<lpage>837</lpage>
<pub-id pub-id-type="doi">10.1002/ptr.1256</pub-id>
<pub-id pub-id-type="pmid">12916091</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Chinese herbal medicinal ingredients inhibit secretion of IL-6, IL-8, E-selectin and TXB2 in LPS-induced rat intestinal microvascular endothelial cells</article-title>
<source/>Immunopharmacol Immunotoxicol.
          <year>2009</year>
<volume>31</volume>
<fpage>550</fpage>
<lpage>555</lpage>
<pub-id pub-id-type="doi">10.3109/08923970902814129</pub-id>
<pub-id pub-id-type="pmid">19874221</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ingkaninan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Phengpa</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yuenyongsawad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Khorana</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Acetylcholinesterase inhibitors from Stephania venosa tuber</article-title>
<source/>J Pharm Pharmacol.
          <year>2006</year>
<volume>58</volume>
<fpage>695</fpage>
<lpage>700</lpage>
<pub-id pub-id-type="doi">10.1211/jpp.58.5.0015</pub-id>
<pub-id pub-id-type="pmid">16640839</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effects of jatrorrhizine on contractile responses of rat ileum</article-title>
<source/>Eur J Pharmacol.
          <year>2011</year>
<volume>663</volume>
<fpage>74</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2011.05.002</pub-id>
<pub-id pub-id-type="pmid">21596029</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Effect of jatrorrhizine on delayed gastrointestinal transit in rat postoperative ileus</article-title>
<source/>J Pharm Pharmacol.
          <year>2012</year>
<volume>64</volume>
<fpage>413</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1111/j.2042-7158.2011.01407.x</pub-id>
<pub-id pub-id-type="pmid">22309273</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pistollato</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease</article-title>
<source/>Nutr Rev.
          <year>2016</year>
<volume>74</volume>
<fpage>624</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="doi">10.1093/nutrit/nuw023</pub-id>
<pub-id pub-id-type="pmid">27634977</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>ZB</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>YZ</given-names>
</name>
</person-group>
<article-title>Main antimicrobial components of Tinospora capillipes, and their mode of action against Staphylococcus aureus</article-title>
<source/>FEBS Lett.
          <year>2007</year>
<volume>581</volume>
<fpage>4179</fpage>
<lpage>4183</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2007.07.056</pub-id>
<pub-id pub-id-type="pmid">17692848</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uemura</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve</article-title>
<source/>Mol Neurodegener.
          <year>2018</year>
<volume>13</volume>
<fpage>21</fpage>
<pub-id pub-id-type="doi">10.1186/s13024-018-0257-5</pub-id>
<pub-id pub-id-type="pmid">29751824</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study</article-title>
<source/>Neurology.
          <year>2017</year>
<volume>88</volume>
<fpage>1996</fpage>
<lpage>2002</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000003961</pub-id>
<pub-id pub-id-type="pmid">28446653</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Leary</surname>
<given-names>OF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus</article-title>
<source/>Eur Neuropsychopharmacol.
          <year>2018</year>
<volume>28</volume>
<fpage>307</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1016/j.euroneuro.2017.12.004</pub-id>
<pub-id pub-id-type="pmid">29426666</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonaz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sinniger</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pellissier</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation</article-title>
<source/>J Physiol.
          <year>2016</year>
<volume>594</volume>
<fpage>5781</fpage>
<lpage>5790</lpage>
<pub-id pub-id-type="doi">10.1113/JP271539</pub-id>
<pub-id pub-id-type="pmid">27059884</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matteoli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Boeckxstaens</surname>
<given-names>GE</given-names>
</name>
</person-group>
<article-title>The vagal innervation of the gut and immune homeostasis</article-title>
<source/>Gut.
          <year>2013</year>
<volume>62</volume>
<fpage>1214</fpage>
<lpage>1222</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2012-302550</pub-id>
<pub-id pub-id-type="pmid">23023166</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cailotto</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuro-anatomical evidence indicating indirect modulation of macrophages by vagal efferents in the intestine but not in the spleen</article-title>
<source/>PLoS One.
          <year>2014</year>
<volume>9</volume>
<fpage>e87785</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0087785</pub-id>
<pub-id pub-id-type="pmid">24489965</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crumeyrolle-Arias</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats</article-title>
<source/>Psychoneuroendocrinology.
          <year>2014</year>
<volume>42</volume>
<fpage>207</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.01.014</pub-id>
<pub-id pub-id-type="pmid">24636517</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>ZS</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Juang</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in Drosophila</article-title>
<source/>Nat Commun.
          <year>2017</year>
<volume>8</volume>
<fpage>24</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-017-00040-6</pub-id>
<pub-id pub-id-type="pmid">28634323</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonfili</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels</article-title>
<source/>Sci Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>2426</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-02587-2</pub-id>
<pub-id pub-id-type="pmid">28546539</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>